Georgia-Pacific Commits $150 Million to Rebuild a Florida Tissue Machine

Georgia-Pacific is spending about $150 million to rebuild a paper machine at its Palatka, Florida, mill, choosing a multiyear modernization rather than replacing the site's tissue production elsewhere. Work has begun and is scheduled for completion in the second quarter of 2028.

The machine dates to 1980 and produces bath tissue sold under the Angel Soft brand. Georgia-Pacific says the rebuild will replace aging equipment while improving safety, reliability, product quality and productivity. The company also said the project will preserve current production capacity, so this is primarily a modernization investment rather than a disclosed volume expansion.

That distinction matters. A capacity project depends on selling more product, while a rebuild can create value through fewer outages, better yields, lower maintenance needs and more consistent quality. Georgia-Pacific did not publish expected cost savings, returns or incremental output, which prevents a precise financial assessment.

The Palatka commitment also provides a useful signal about capital allocation inside the privately held company. Georgia-Pacific operates more than 150 facilities and employs about 30,000 people, while its consumer brands reach nearly 60 million U.S. households. Directing $150 million to an existing mill suggests management expects the tissue franchise and the Palatka site to remain important well beyond the 2028 completion date.

Execution will be the key risk. Rebuilding a machine while protecting ongoing production requires careful scheduling, and the benefits will not be fully visible for more than a year. Investors cannot buy Georgia-Pacific shares directly, but the project is relevant to suppliers and competitors because it shows a major tissue producer prioritizing reliability and unit economics over a headline increase in capacity.